Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Replimune (REPL) EBIT (2017 - 2025)

Replimune has reported EBIT over the past 9 years, most recently at -$71.9 million for Q4 2025.

  • Quarterly results put EBIT at -$71.9 million for Q4 2025, down 8.86% from a year ago — trailing twelve months through Dec 2025 was -$325.9 million (down 35.2% YoY), and the annual figure for FY2025 was -$261.6 million, down 11.44%.
  • EBIT reached -$71.9 million in Q4 2025 per REPL's latest filing, up from -$84.3 million in the prior quarter.
  • Across five years, EBIT topped out at -$22.2 million in Q1 2021 and bottomed at -$90.4 million in Q2 2025.
  • Median EBIT over the past 5 years was -$56.1 million (2023), compared with a mean of -$53.0 million.
  • The largest annual shift saw EBIT crashed 65.67% in 2023 before it grew 7.7% in 2024.
  • Over 5 years, EBIT stood at -$29.7 million in 2021, then plummeted by 40.18% to -$41.6 million in 2022, then crashed by 35.82% to -$56.5 million in 2023, then decreased by 16.77% to -$66.0 million in 2024, then decreased by 8.86% to -$71.9 million in 2025.
  • Business Quant data shows EBIT for REPL at -$71.9 million in Q4 2025, -$84.3 million in Q3 2025, and -$90.4 million in Q2 2025.